Turn Therapeutics
Bradley Burnam is the Founder/Chief Executive Officer of Turn Therapeutics, formerly known as Global Health Solutions, LLC. Turn Therapeutics specializes in the research, development, and commercialization of innovative products for infection control, skin, and wound care. They distribute their proprietary technologies through a nationwide network of distributors and strategic partners. Bradley's role involves reducing the human and economic costs associated with skin disease, wounds, and infections. In addition to their work at Turn Therapeutics, Bradley serves as a member of the UCLA Social Sciences Dean's Advisory Board.
Bradley Burnam earned a Bachelor's degree from UCLA, where they attended from 1996 to 2001. Following their undergraduate studies, they pursued further education at Stanford University from 2001 to 2002, where they obtained a Master's degree. The field of study for both degrees is not provided.
This person is not in any teams
This person is not in any offices
Turn Therapeutics
Turn Therapeutics is a pharmaceutical company that is dedicated to reducing the human and economic costs of infection and skin disease. Turn Therapeutics was founded to reduce antibiotic resistance through best-in-class acute and chronic wound care products. The company's mission is to leverage expertise in drug delivery to create disruptiveproducts for high need indications.It was founded in 2015 and its headquarters is located in Calabasas, California.